Ahamed F, Eppler N, Jones E, Zhang Y
Livers. 2024; 4(3):455-478.
PMID: 39328386
PMC: 11426415.
DOI: 10.3390/livers4030033.
Mounika N, Mungase S, Verma S, Kaur S, Deka U, Ghosh T
Inflammation. 2024; 48(1):25-41.
PMID: 38676759
DOI: 10.1007/s10753-024-02035-0.
Jha D, Prajapati S, Deb P, Jaiswal M, Mazumder P
Mol Biol Rep. 2024; 51(1):209.
PMID: 38270737
DOI: 10.1007/s11033-023-08962-9.
Yan P, Wu Y, Dan X, Wu X, Tang Q, Chen X
Front Endocrinol (Lausanne). 2023; 14:1064125.
PMID: 36909318
PMC: 9998996.
DOI: 10.3389/fendo.2023.1064125.
Dong X, Lu S, Tian Y, Ma H, Wang Y, Zhang X
J Adv Res. 2023; 55:131-144.
PMID: 36801384
PMC: 10770097.
DOI: 10.1016/j.jare.2023.02.007.
Menopause-Related Changes in Body Composition Are Associated With Subsequent Bone Mineral Density and Fractures: Study of Women's Health Across the Nation.
Shieh A, Karlamangla A, Karvonen-Guttierez C, Greendale G
J Bone Miner Res. 2022; 38(3):395-402.
PMID: 36542065
PMC: 10023299.
DOI: 10.1002/jbmr.4759.
Extrahepatic factors in hepatic immune regulation.
Zhang S, Lu S, Li Z
Front Immunol. 2022; 13:941721.
PMID: 36052075
PMC: 9427192.
DOI: 10.3389/fimmu.2022.941721.
Three-Dimensional Organoids as a Model to Study Nonalcoholic Fatty Liver Disease.
Park Y, Thadasina D, Bolujo I, Isidan A, Cross-Najafi A, Lopez K
Semin Liver Dis. 2022; 42(4):423-433.
PMID: 36044928
PMC: 11567686.
DOI: 10.1055/a-1934-5588.
The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis.
Du W, Wang L
Front Immunol. 2022; 13:936196.
PMID: 35837401
PMC: 9274003.
DOI: 10.3389/fimmu.2022.936196.
Lowering -6/-3 Ratio as an Important Dietary Intervention to Prevent LPS-Inducible Dyslipidemia and Hepatic Abnormalities in Mice.
Park S, Lee J, Lee J, Lee J, Byun J, Kim I
Int J Mol Sci. 2022; 23(12).
PMID: 35742829
PMC: 9224551.
DOI: 10.3390/ijms23126384.
Association between overweight and anemia in Moroccan adolescents: a cross-sectional study.
Mehdad S, Benaich S, Hamdouchi A, Bouhaddou N, Azlaf M, El Menchawy I
Pan Afr Med J. 2022; 41:156.
PMID: 35573439
PMC: 9058990.
DOI: 10.11604/pamj.2022.41.156.20927.
TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD.
Caddeo A, Kowalik M, Serra M, Runfola M, Bacci A, Rapposelli S
Int J Mol Sci. 2021; 22(23).
PMID: 34884910
PMC: 8657920.
DOI: 10.3390/ijms222313105.
Genetics Is of the Essence to Face NAFLD.
Meroni M, Longo M, Tria G, Dongiovanni P
Biomedicines. 2021; 9(10).
PMID: 34680476
PMC: 8533437.
DOI: 10.3390/biomedicines9101359.
Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice.
Haberl E, Pohl R, Rein-Fischboeck L, Horing M, Krautbauer S, Liebisch G
Lipids Health Dis. 2021; 20(1):135.
PMID: 34629057
PMC: 8502393.
DOI: 10.1186/s12944-021-01567-w.
Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology.
Della Torre S
Cells. 2021; 10(9).
PMID: 34572151
PMC: 8470830.
DOI: 10.3390/cells10092502.
Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis.
Kumar S, Duan Q, Wu R, Harris E, Su Q
Adv Drug Deliv Rev. 2021; 176:113869.
PMID: 34280515
PMC: 11792083.
DOI: 10.1016/j.addr.2021.113869.
Deep learning-based automated quantification of the hepatorenal index for evaluation of fatty liver by ultrasonography.
Cha D, Kang T, Min J, Joo I, Sinn D, Ha S
Ultrasonography. 2021; 40(4):565-574.
PMID: 33966363
PMC: 8446496.
DOI: 10.14366/usg.20179.
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-A Condition Associated with Heightened Sympathetic Activation.
Carnagarin R, Tan K, Adams L, Matthews V, Kiuchi M, Marisol Lugo Gavidia L
Int J Mol Sci. 2021; 22(8).
PMID: 33921881
PMC: 8073135.
DOI: 10.3390/ijms22084241.
The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation.
Yang Z, Roth K, Agarwal M, Liu W, Petriello M
J Nutr Biochem. 2021; 95:108633.
PMID: 33789150
PMC: 8355060.
DOI: 10.1016/j.jnutbio.2021.108633.
Magnesium accumulation upon cyclin M4 silencing activates microsomal triglyceride transfer protein improving NASH.
Simon J, Goikoetxea-Usandizaga N, Serrano-Macia M, Fernandez-Ramos D, Saenz de Urturi D, Gruskos J
J Hepatol. 2021; 75(1):34-45.
PMID: 33571553
PMC: 8217299.
DOI: 10.1016/j.jhep.2021.01.043.
